Home/Enara Bio/Scott Drutman
SD

Scott Drutman

CMO

Enara Bio

Therapeutic Areas

Enara Bio Pipeline

DrugIndicationPhase
ENA101 (targeting DARKFOX)Solid TumorsPre-clinical